✦ LIBER ✦

Concomitant radiochemotherapy with 5-FU and cisplatin for invasive bladder cancer

✍ Scribed by Stefan Birkenhake; Susanne Leykamm; Peter Martus; Rolf Sauer

Book ID: 110658880
Publisher: Springer
Year: 1999
Tongue: German
Weight: 554 KB
Volume: 175
Category: Article
ISSN: 0179-7158
DOI: 10.1007/bf02742341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accelerated superfractionated radiothera

Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer

✍ A.Aydin Yavuz; Melek N Yavuz; Guner K Ozgur; Fatma Colak; Rasin Ozyavuz; Emel Ci 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Combined 5-FU, cisplatin and accelerated

Combined 5-FU, cisplatin and accelerated split course irradiation for invasive transitionnal-cell carcinoma of the bladder

✍ M. Housset; B. Dufour; C. Maulard; Y. Chrdtlen; J.P. Haliez; S. Delanian; F. Bai 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Cisplatin and external beam radiation in

Cisplatin and external beam radiation in patients with invasive bladder cancer

✍ William U. Shipley 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Combined cisplatin and radiation therapy

Combined cisplatin and radiation therapy in patients with invasive bladder cancer

✍ Y. Mori; H. Ihara; H. Shima; K. Shimada; M. Arima; F. Ikoma 📂 Article 📅 1990 🏛 Springer Netherlands 🌐 English ⚖ 1004 KB

Radiotherapy and cisplatin for invasive

Radiotherapy and cisplatin for invasive bladder cancer: Criteria of “complete response”

✍ R. Sauer 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Invasive bladder carcinoma: A pilot stud

Invasive bladder carcinoma: A pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatin

✍ Abderrahim Zouhair; Mahmut Ozsahin; Dominique Schneider; Jean Bauer; Patrice Jic 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 227 KB

## Abstract From November 1992 to December 1997, 25 patients (inoperable or refusing cystectomy) were included in a prospective study to assess the feasibility, tolerance, and curative potential of accelerated radiotherapy (RT) and concomitant cisplatin. Median age was 74 years (range 49–86). Stage